Purisys is a leading developer and manufacturer of cannabinoid ingredients and a CDMO providing custom manufacturing and reference standards primarily for pharmaceutical customers.

In 2019, Purisys was spun off from Noramco to capitalize and focus on its strengths in clinical API development and manufacturing, synthetically manufactured cannabinoids and finished products.

For more information, please visit: https://purisys.com/